General Information of the Compound
| Compound ID |
CP0421750
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-methyl-5-[[5-[methylsulfonyl-(6-phenyl-1,3-benzothiazol-2-yl)methyl]-1,3,4-oxadiazol-2-yl]methyl]imidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H19N5O5S2
|
||||||||||||||||||
| Molecular Weight |
497.558
|
||||||||||||||||||
| Canonical SMILES |
CC1(Cc2nnc(o2)C(c2nc3ccc(cc3s2)-c2ccccc2)S(C)(=O)=O)NC(=O)NC1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H19N5O5S2/c1-22(20(28)24-21(29)25-22)11-16-26-27-18(32-16)17(34(2,30)31)19-23-14-9-8-13(10-15(14)33-19)12-6-4-3-5-7-12/h3-10,17H,11H2,1-2H3,(H2,24,25,28,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NENGVIVEEOLDAA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01303, Endothelial lipase
Protein ID: PT02459, Hepatic triacylglycerol lipase